An unmet need for long-term follow-up in Hodgkin's lymphoma?

Beyond maximum grade: key regulatory considerations in adverse event reporting.

The Lancet. Haematology·2026

Large B-cell lymphoma: The LYSA pragmatic guidelines.

European journal of cancer (Oxford, England : 1990)·2025

Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?

British journal of haematology·2022

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.

The Lancet. Haematology·2022

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma.

HemaSphere·2021

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.

Blood advances·2021

High time for risk-adapted treatment in mantle cell lymphoma.

The Lancet. Haematology·2026

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

The Lancet. Haematology·2026

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

The Lancet. Haematology·2026

CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.

The Lancet. Haematology·2026

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.

The Lancet. Haematology·2026

Pharmacogenomics and artificial intelligence in cardiovascular disease: emerging tools for precision medicine.

Pharmacogenomics·2026

Single versus double burr-hole drainage for chronic subdural hematoma: a systematic review and meta-analysis of 2,359 patients.

Neurological research·2026

Myeloid Dendritic Cell Counts and Coronary Heart Disease: a Bidirectional Mendelian Randomization Study.

Clinical laboratory·2026

When Transfer Is Impossible: Emergency Management of Perforated Necrotizing Enterocolitis in a Neonate With Uncorrected Dextro-Transposition of the Great Arteries.

Cureus·2026

Determinants of HIV, Hepatitis B, and Hepatitis C Infections Among Preoperative Patients in a Tertiary Hospital in the Eastern Democratic Republic of Congo.

Infection and drug resistance·2026

Integrative transcriptomics and human tibial artery validation identify ADAM12, PDK4, and RUNX1 as peripheral artery disease-associated genes enriched in calcified tibial arteries.

JVS-vascular science·2026

Related Experiment Videos

An unmet need for long-term follow-up in Hodgkin's lymphoma?

Related Concept Videos

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.

High time for risk-adapted treatment in mantle cell lymphoma.

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.

Pharmacogenomics and artificial intelligence in cardiovascular disease: emerging tools for precision medicine.

Single versus double burr-hole drainage for chronic subdural hematoma: a systematic review and meta-analysis of 2,359 patients.

Myeloid Dendritic Cell Counts and Coronary Heart Disease: a Bidirectional Mendelian Randomization Study.

When Transfer Is Impossible: Emergency Management of Perforated Necrotizing Enterocolitis in a Neonate With Uncorrected Dextro-Transposition of the Great Arteries.

Determinants of HIV, Hepatitis B, and Hepatitis C Infections Among Preoperative Patients in a Tertiary Hospital in the Eastern Democratic Republic of Congo.

Integrative transcriptomics and human tibial artery validation identify ADAM12, PDK4, and RUNX1 as peripheral artery disease-associated genes enriched in calcified tibial arteries.

Related Experiment Videos

An unmet need for long-term follow-up in Hodgkin's lymphoma?

Related Concept Videos

Related Articles